Reach Us +44-7480-022449

Abstract

Comparing the effect of Monotherapies of Hyperlipidemia over Placebo Treatment

This study was a placebo controlled, single centre prospective study to evaluate and compare the hypolipidemic activity of monotherapies of simvastatin (20 mg),ezetimibe(10 mg) and omega-3 fatty acids(4 g) over placebo treatment. Human dyslipidemic male subjects who had been selected based on the inclusionand exclusion criteria ,were divided into four groups of 21,20,22 and 20 subjects. The serum lipid profile level of these subjects were determined before and after 90 days treatments of placebo and above monotherapies. After 90 days of treatment, LDL cholesterol and total cholesterol levels were reduced significantly in simvastatin and ezetimibe groups while triglycerides level was significantly reduced and HDL cholesterol level increased in omega-3 fatty acids group compared to placebo group.


Author(s): Clement Atlee W, M Vasudevan

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Flyer image
Abstracted/Indexed in
  • Chemical Abstracts Service (CAS)
  • Index Copernicus
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs